XCATH

XCath develops next-generation endovascular robotic systems and steerable guidewires to treat life-threatening conditions like cerebrovascular disorders. With strategically located campuses in Houston, Texas—home to the world's largest medical center—and Pangyo, South Korea, often referred to as the Silicon Valley of Korea, XCath is committed to bringing its innovative solutions to patients around the world.  Our Iris System is the only endovascular robotic system in development to achieve local or telerobotic neurointerventional treatment and is also the world’s only triaxial neurovascular robot to perform treatment.  With the Iris System now FDA Breakthrough Device Designated for remote robotic-assisted mechanical thrombectomy in acute ischemic stroke, follow our journey to democratize stroke care. 

Disclaimer: The Iris Surgical Robotic System remains under development and is not yet cleared for commercial distribution.